Multicenter, Randomized, Parallel Study of Angiotensin Receptor Blockade (Olmesartan) on mortality and morbidity in Chronic Hemodialysis Patients Among Okinawa Dialysis Study Group.

Trial Profile

Multicenter, Randomized, Parallel Study of Angiotensin Receptor Blockade (Olmesartan) on mortality and morbidity in Chronic Hemodialysis Patients Among Okinawa Dialysis Study Group.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Antihypertensives
  • Indications Cardiovascular disorders; Hypertension
  • Focus Therapeutic Use
  • Acronyms OCTOPUS
  • Most Recent Events

    • 25 Jan 2013 Status changed from active, no longer recruiting to completed.
    • 25 Jan 2013 Primary endpoint 'Death-rate' has not been met.
    • 25 Jan 2013 Primary endpoint 'Cardiovascular-event-rate' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top